HC Wainwright Brokers Boost Earnings Estimates for TPST
Tempest Therapeutics, Inc. (NASDAQ:TPST – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 earnings estimates for Tempest Therapeutics in a research report issued to clients and investors on Thursday, May 15th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($3.23) per share for the quarter, up from their […]
Tempest Therapeutics, Inc. (NASDAQ:TPST – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 earnings estimates for Tempest Therapeutics in a research report issued to clients and investors on Thursday, May 15th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($3.23) per share for the quarter, up from their […]
